CJC-1295 + Ipamorelin (5mg/5mg) · Research brief

CJC-1295 IU per Tick Insulin Syringe Dosing Guide

Real Peptides Research TeamEditorial

Updated April 23, 20269 min read

53 WORDS

Short answer

Key takeaways

CJC-1295 IU per tick insulin syringe dosing is calculated as (peptide mg ÷ water mL) × 0.01mL per tick, not a fixed peptide-specific unit like insulin.
A 2mg vial reconstituted with 2mL bacteriostatic water yields 1mg/mL concentration, where each 10 IU tick on a U-100 syringe contains 100mcg of CJC-1295.
U-100, U-50, and TB syringes all use 0.01mL per tick. The difference is total barrel capacity, not tick volume.
Doses below 50mcg require diluting the concentration to 0.5mg/mL or lower to achieve single-tick precision within acceptable margin of error.
Water volume precision during reconstitution directly affects dose accuracy. A 5% volume error becomes a 5% dose error across every injection from that vial.
Tick value changes with every vial concentration. Recalculate before drawing from any new reconstituted vial, even if the peptide type is the same.

The most common error researchers make with CJC-1295 isn't needle technique or injection site selection. It's miscalculating the dose per tick mark on a standard insulin syringe. Unlike insulin, which is measured in standardised International Units (IU) with fixed concentrations, research peptides like CJC-1295 arrive as lyophilised powder requiring reconstitution with bacteriostatic water. The concentration you create determines what each tick mark on your syringe represents in micrograms, and that calculation changes with every vial size and reconstitution volume you use.

Our team has worked with thousands of researchers navigating peptide protocols. The gap between doing it right and doing it catastrophically wrong comes down to understanding that IU markings on insulin syringes are volumetric measurements. Not peptide-specific dose measurements.

How do you calculate CJC-1295 IU per tick on an insulin syringe?

CJC-1295 IU per tick insulin syringe dosing requires calculating your reconstituted concentration first. If you reconstitute a 2mg vial with 2mL bacteriostatic water, you create a 1mg/mL solution. On a 1mL (100 IU) insulin syringe, each 10 IU tick equals 0.1mL, which contains 100mcg of CJC-1295. The formula is: (total peptide mg ÷ total water mL) × syringe tick volume in mL = micrograms per tick.

Direct Answer: IU Markings Are Volume, Not Peptide Dose

Here's what most reconstitution guides gloss over: IU markings on insulin syringes represent volume only. Specifically, 0.01mL per unit on a U-100 syringe. The phrase "CJC-1295 IU per tick" is technically imprecise because peptides aren't measured in International Units the way insulin is. What you're actually calculating is micrograms of peptide per volumetric tick mark based on the concentration you created during reconstitution. The calculation sequence is always: (1) determine your target dose in micrograms, (2) calculate your reconstituted concentration in mg/mL, (3) convert that to mcg per 0.01mL (one IU tick), (4) count the ticks needed to reach your target dose. This article covers the exact math for standard vial sizes, how tick calculations change with syringe type, and the reconstitution mistakes that silently invalidate every dose you draw afterward.

Reconstitution Math: How Vial Size and Water Volume Determine Tick Value

CJC-1295 typically ships as 2mg or 5mg lyophilised powder in sterile vials. The amount of bacteriostatic water you add creates the concentration. And concentration is what determines the peptide content of each syringe tick. Standard reconstitution volumes are 2mL for a 2mg vial (yielding 1mg/mL) or 2.5mL for a 5mg vial (yielding 2mg/mL). A 1mL U-100 insulin syringe has 100 total tick marks, each representing 1 IU or 0.01mL. At 1mg/mL concentration, each 10 IU tick (0.1mL) contains 100mcg of CJC-1295. At 2mg/mL concentration, that same 10 IU tick contains 200mcg.

The formula: (Total peptide in mg ÷ Total water in mL) × Tick volume in mL = Micrograms per tick. For a 2mg vial reconstituted with 2mL water: (2mg ÷ 2mL) × 0.01mL per tick = 0.01mg per tick = 10mcg per single IU mark. For common research doses of 100mcg or 200mcg, you'd draw 10 ticks or 20 ticks respectively from that 1mg/mL solution. Researchers who skip this calculation and draw "the usual 10 units" without knowing their actual concentration risk severe under- or overdosing. Concentration varies with every vial. Calculate every time.

Water volume precision matters. Adding 2.1mL instead of 2.0mL to a 2mg vial dilutes the concentration from 1mg/mL to 0.95mg/mL, reducing each 10-tick dose from 100mcg to 95mcg. Across weeks of dosing, that 5% error compounds into measurable outcome differences. Use a calibrated syringe to measure bacteriostatic water. Eyeballing the meniscus is insufficient.

Syringe Type Variations: U-100 vs U-50 vs Fixed-Dose Syringes

Not all insulin syringes use the same tick-to-volume ratio. U-100 syringes (the most common) have 100 units per 1mL barrel. Each tick equals 0.01mL. U-50 syringes have 50 units per 0.5mL barrel. Each tick still equals 0.01mL, but the total capacity is half. If you're used to drawing 20 ticks on a U-100 syringe for a 200mcg dose (at 1mg/mL concentration), switching to a U-50 syringe doesn't change the tick count. 20 ticks still delivers 0.2mL, which still contains 200mcg at that concentration. The difference is barrel capacity, not tick volume.

Fixed-dose syringes (0.3mL, 0.5mL) follow the same principle but with fewer total ticks. A 0.3mL U-100 syringe has 30 total tick marks. Each still represents 0.01mL. The math doesn't change; the range does. These smaller syringes are preferred for low-volume peptide dosing because they allow more precise tick counting when your dose is 10–30 ticks instead of spreading across a larger barrel.

Tubercular (TB) syringes are 1mL capacity but marked in 0.01mL increments without the "unit" label. Functionally identical to U-100 syringes for peptide use. The key distinction is labeling clarity: TB syringes display volume directly (0.1mL, 0.2mL), while insulin syringes display units (10 IU, 20 IU). Both measure the same volume; TB syringes just skip the IU terminology entirely. For CJC-1295 dosing, either works. But TB syringes eliminate one layer of mental conversion.

Dose Precision: Why "Rounding to the Nearest Tick" Fails Below 50mcg

Insulin syringe tick marks represent 10mcg increments at 1mg/mL concentration. For target doses of 100mcg, 200mcg, or 300mcg, this granularity is acceptable. You're working with whole multiples of 10. But for microdosing protocols targeting 25mcg or 75mcg, standard U-100 syringes lack sufficient resolution. The closest you can measure to 25mcg at 1mg/mL is either 20mcg (2 ticks) or 30mcg (3 ticks). A 20–30% margin of error.

The solution is concentration adjustment, not syringe substitution. If you reconstitute a 2mg vial with 4mL bacteriostatic water instead of 2mL, you create a 0.5mg/mL solution. At this concentration, each tick equals 5mcg instead of 10mcg, allowing precise measurement of 25mcg (5 ticks) or 75mcg (15 ticks). The trade-off is injection volume: a 200mcg dose now requires 40 ticks (0.4mL) instead of 20 ticks (0.2mL). For subcutaneous peptide administration, volumes up to 0.5mL per injection site are well-tolerated, so this dilution strategy is practical for most protocols.

Some researchers attempt half-tick estimation. Visually splitting the space between two tick marks to approximate intermediate doses. This introduces human error and isn't reproducible across injections. Diluting the concentration to match your syringe's resolution is the correct approach.

CJC-1295 IU per Tick Insulin Syringe: Concentration Table

| Vial Size | Water Volume | Concentration | 1 Tick (1 IU) | 10 Ticks (10 IU) | 20 Ticks (20 IU) | Precision Level |
|—|—|—|—|—|—|
| 2mg | 2mL | 1mg/mL | 10mcg | 100mcg | 200mcg | Standard |
| 2mg | 4mL | 0.5mg/mL | 5mcg | 50mcg | 100mcg | High (microdosing) |
| 5mg | 2.5mL | 2mg/mL | 20mcg | 200mcg | 400mcg | High-dose protocols |
| 5mg | 5mL | 1mg/mL | 10mcg | 100mcg | 200mcg | Standard |
| 2mg | 1mL | 2mg/mL | 20mcg | 200mcg | 400mcg | High-dose (low volume) |

This table assumes U-100 insulin syringes (1 IU = 0.01mL). At 1mg/mL, each tick delivers 10mcg. Ideal for 100–300mcg dosing. At 0.5mg/mL, each tick delivers 5mcg. Necessary for sub-50mcg precision. At 2mg/mL, each tick delivers 20mcg. Used when minimising injection volume is prioritised over tick-count precision. Always calculate your specific concentration before drawing. Do not assume tick values carry over between vials.

What If: CJC-1295 Dosing Scenarios

What If I Accidentally Added Too Much Water During Reconstitution?

Measure the exact volume you added using a calibrated syringe, then recalculate your concentration. If you added 2.3mL to a 2mg vial instead of 2mL, your concentration is 2mg ÷ 2.3mL = 0.87mg/mL. Each 10 IU tick now contains 87mcg instead of 100mcg. Adjust your tick count upward to compensate: for a 200mcg dose, draw 23 ticks instead of 20. Do not discard the vial. Diluted peptide is still viable; you're just drawing a larger volume per dose. Mark the vial with the actual concentration to avoid confusion on subsequent draws.

What If My Target Dose Doesn't Align With Whole Tick Marks?

If your protocol calls for 150mcg and you're working with a 1mg/mL solution (10mcg per tick), 15 ticks delivers exactly 150mcg. No rounding needed. But if you need 175mcg, standard U-100 syringes can't measure that precisely at 1mg/mL concentration (you'd be choosing between 170mcg or 180mcg). Reconstitute your next vial at 0.5mg/mL instead, where each tick equals 5mcg and 35 ticks delivers exactly 175mcg. Concentration flexibility is how you achieve dose precision without guessing between tick marks.

What If I'm Using a 0.3mL Syringe Instead of 1mL?

Tick volume remains 0.01mL per unit on U-100 syringes regardless of barrel size. A 0.3mL syringe just has 30 total ticks instead of 100. If your dose is 100mcg at 1mg/mL concentration, you still draw 10 ticks. The 0.3mL syringe works fine for doses up to 300mcg at 1mg/mL or 150mcg at 2mg/mL. Beyond that, you'd exceed barrel capacity and need to switch to a larger syringe or dilute your concentration further. Smaller syringes improve visual precision for low-dose protocols but don't change the math.

The Unflinching Truth About Peptide Dosing Errors

Here's the honest answer: most researchers who think they're dosing CJC-1295 accurately are operating on flawed assumptions carried over from previous vials or protocols. The most dangerous mistake isn't drawing the wrong number of ticks. It's assuming tick value stays constant across different reconstitution batches. A researcher who draws "the usual 20 units" without recalculating concentration per vial will eventually administer the wrong dose, possibly by a factor of two or more if they switch from a 2mg vial reconstituted at 1mg/mL to a 5mg vial reconstituted at 2mg/mL. Those same 20 ticks now contain 400mcg instead of 200mcg.

The second most common error is trusting visual estimation for fractional doses. "Half a tick" or "between the 15 and 16 mark" is not reproducible dosing. It's guessing. If your protocol requires that level of precision, the correct response is diluting the concentration until whole tick marks align with your target dose. Precision comes from math, not eyeballing meniscus curves under poor lighting.

Peptide research demands the same dosing rigor as pharmaceutical compounding. If you wouldn't guess insulin doses for a diabetic patient, don't guess peptide doses for your research model. Calculate every vial. Verify your math twice. Mark concentrations on every vial label. The peptides we supply are research-grade and amino-acid sequenced for purity. But purity means nothing if the dose calculation is wrong.

CJC-1295 IU per tick insulin syringe calculations aren't optional background knowledge. They're the foundation of every dose you draw. A researcher who masters this math once and applies it consistently will see reproducible outcomes. A researcher who skips it will see outcome variance they can't explain. Because half their doses were 30% off target and they never knew it. This isn't peptide failure; it's protocol failure. The compound works when the dose is correct. Make the dose correct every time.

References

Peer-reviewed sources on CJC-1295 indexed in PubMed, listed for research context. Real Peptides supplies CJC-1295 for laboratory research use only.

Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Substance use & misuse, 2016. PMID 26771670. doi:10.3109/10826084.2015.1082595
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug testing and analysis, 2010. PMID 21204297. doi:10.1002/dta.233
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 2009. PMID 19386527. doi:10.1016/j.ghir.2009.03.001
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism, 2006. PMID 16352683. doi:10.1210/jc.2005-1536
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American journal of physiology. Endocrinology and metabolism, 2006. PMID 16822960. doi:10.1152/ajpendo.00201.2006
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of clinical endocrinology and metabolism, 2006. PMID 17018654. doi:10.1210/jc.2006-1702
Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology, 2005. PMID 15817669. doi:10.1210/en.2004-1286

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

The tick count depends on your reconstituted concentration, not a fixed IU standard. If you reconstituted a 2mg vial with 2mL bacteriostatic water (creating 1mg/mL), you would draw 20 IU ticks on a U-100 syringe to deliver 200mcg. If you reconstituted the same 2mg vial with 4mL water (creating 0.5mg/mL), you would draw 40 IU ticks for the same 200mcg dose. Calculate concentration first, then determine tick count — never assume tick values from previous vials.

Yes — U-50 syringes have the same 0.01mL per tick volume as U-100 syringes, just with half the total barrel capacity (0.5mL instead of 1mL). For a 200mcg dose at 1mg/mL concentration, you would still draw 20 ticks on either syringe type. The difference is that U-50 syringes max out at 50 total ticks, so doses above 250mcg at 1mg/mL concentration would exceed barrel capacity and require either a U-100 syringe or a more concentrated reconstitution.

A single miscalculated dose — whether too high or too low — does not cause permanent harm for most research models, but it disrupts protocol consistency and invalidates comparative data from that administration. CJC-1295 DAC has a half-life of approximately 6–8 days, meaning a dose error compounds across multiple days before clearance. If you suspect a calculation error, verify your math immediately, recalculate the concentration from your reconstitution records, and adjust future draws accordingly. Document the error so outcome variance can be attributed correctly.

TB syringes are marked in 0.01mL increments directly rather than IU, but the volumetric math is identical to U-100 insulin syringes. If your CJC-1295 is reconstituted at 1mg/mL and you need 100mcg, draw to the 0.1mL line (which equals 10 ticks on an insulin syringe). TB syringes eliminate the IU-to-mL mental conversion step, making them slightly easier for researchers unfamiliar with insulin dosing terminology. The concentration formula remains (peptide mg ÷ water mL) × syringe volume in mL.

Yes — adjusting reconstitution concentration is the correct method for achieving dose precision that matches your syringe’s tick resolution. For microdosing protocols requiring 25mcg or 50mcg doses, reconstitute at 0.5mg/mL so each tick delivers 5mcg. For high-dose protocols minimising injection volume, reconstitute at 2mg/mL so each tick delivers 20mcg. The peptide remains stable across these concentration ranges when stored at 2–8°C and used within 28 days post-reconstitution.

Yes — concentration varies with vial size and the exact volume of bacteriostatic water you add, so tick values change between vials even for the same peptide. A 2mg vial reconstituted with 2mL yields 1mg/mL; a 5mg vial reconstituted with 2.5mL yields 2mg/mL — same peptide, different tick dosing. Always recalculate (peptide mg ÷ water mL) × 0.01mL and mark the concentration on the vial label immediately after reconstitution to prevent cross-vial confusion.

The most common error is drawing the same tick count across different vial concentrations without recalculating dose. A researcher who reconstitutes one vial at 1mg/mL and draws 20 ticks for 200mcg may later reconstitute a 5mg vial at 2mg/mL and draw the same 20 ticks — now delivering 400mcg instead of 200mcg. Tick count is not transferable between concentrations. The second most common error is attempting to visually estimate fractional doses (half-ticks) instead of diluting the concentration to align whole ticks with target doses.

CJC-1295 reconstituted with bacteriostatic water and stored at 2–8°C (refrigerated) maintains structural stability and potency for approximately 28 days post-reconstitution. Beyond this window, peptide degradation accelerates — not necessarily rendering it inactive, but reducing dose consistency below research-grade standards. Mark every reconstituted vial with the date and discard after 28 days even if solution remains. Temperature excursions above 8°C cause irreversible denaturation that neither appearance nor home potency testing can detect.

No — both peptides are measured identically using the same concentration-to-tick calculation. The DAC (Drug Affinity Complex) modification affects half-life and dosing frequency (CJC-1295 DAC is dosed weekly; no-DAC is dosed daily), but it does not change how you calculate micrograms per tick. A 2mg vial of either variant reconstituted with 2mL bacteriostatic water yields 1mg/mL, and each 10 IU tick contains 100mcg. The pharmacokinetics differ post-injection, not the dosing math.

Different protocols optimise for different priorities — lower concentrations (more water) improve dose precision for microdosing; higher concentrations (less water) reduce injection volume for high-dose protocols. A 2mg vial can be reconstituted with anywhere from 1mL to 4mL bacteriostatic water depending on whether you prioritise minimising injection volume or maximising per-tick dose granularity. Both are valid; the choice depends on your target dose range and syringe type. Always calculate your actual concentration rather than assuming guide defaults apply to your specific setup.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA